Navigation Links
Breckenridge Pharmaceutical Signs Long Term Agreement with Helm AG (Hamburg, Germany)
Date:1/7/2008

BOCA RATON, Fla., Jan. 7 /PRNewswire/ -- Breckenridge announced today that it has entered into an agreement with Helm AG to develop and manufacture a generic tablet ANDA product. Breckenridge expects to file an ANDA with the FDA in January 2008. Upon approval by the FDA, Helm AG will supply and Breckenridge will market and distribute the product on an exclusive basis.

Under terms of the agreement, Breckenridge will submit an ANDA to the U.S. Food and Drug Administration (FDA) for the product which as been developed by Helm AG. The product currently shows U.S. sales of approximately $800 million.

About Breckenridge:

Breckenridge Pharmaceutical is a privately held pharmaceutical marketing, research and development company founded in 1983 that markets a broad range of ValuBrand(TM) and Generic prescription products in many therapeutic categories. The Breckenridge label is recognized by Wholesalers, Distributors, Chains, and Managed Care Accounts, as well as Retail Pharmacies nationwide. The company markets over 100 products, more than 150 sku's, in a variety of dosage forms including: Tablets, Capsules, Soft Gel Capsules, Liquids, Suspensions and Topical preparations. http://www.bpirx.com

About Helm AG:

Helm AG is an international chemical and pharmaceutical organization and a multifunctional marketing group which operates as a link between producers and industrial end users.

With branch offices and participations in 32 countries HELM provides a wide range of services including marketing, distribution, production, logistics, generic development and registration. http://www.helmag.com

For Further Information, please contact:

Breckenridge Pharmaceutical Helm New York, Inc.

Larry Lapila, Vice President Boy Ehlers, Vice President

Business Development Pharmaceutical Division

TEL: 860-828-8140 TEL: 732-981-1160

FAX: 860-828-8142 FAX: 732-981-0965

e-Mail: llapila@bpirx.com behlers@helmnewyork.com


'/>"/>
SOURCE Breckenridge Pharmaceutical
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Patient-Centric Healthcare Study Reveals Key Insights for Pharmaceutical Marketers
2. KV Pharmaceutical Company Announces NYSE Listing Extension
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
4. Pharmaceutical Sales: Best Practices for Pharmaceutical Sales Success
5. NPS Pharmaceuticals to Present at the JPMorgan 26th Annual Healthcare Conference on January 9, 2008
6. Gerresheimer Expands its Pharmaceutical Plastic Operations Into Southern Europe and South America
7. ISTA Pharmaceuticals Submits New Drug Application for Xibrom(TM) QD (once-daily)
8. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc.
9. Idenix Pharmaceuticals to Present at the JP Morgan 26th Annual Healthcare Conference
10. Cogentus Pharmaceuticals Completes $62.5 Million Private Financing
11. Par Pharmaceutical Reports Third-Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Fort Worth, TX (PRWEB) , ... February 21, 2017 , ... ... planning assistance to communities in and around Tarrant County, is embarking on a six ... to research cures and treatments for cancer. , Cancer is one of the deadliest ...
(Date:2/21/2017)... ... February 21, 2017 , ... American Veterinarian™, the ... will be launching its first bi-monthly issue of 2017 in February. The inaugural ... management, and One Health. , In making the announcement, American Veterinarian™ Publisher ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... during Black History Month (officially African American History Month ). ... American society of a diverse race of people, but also the opportunity to ...
(Date:2/21/2017)... ... February 21, 2017 , ... HIMSS ... The connected care demonstration spanned multiple health information systems including OpenEMR, EMRDirect, ... of providers have no Health Information Exchange outside of faxing. Medal’s innovative technology ...
(Date:2/21/2017)... ... 2017 , ... A February 6 article on Healio describes a ... that the treatments have led to significant improvements in weight loss and other health ... also noted very few problematic results relating to the treatment. Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... The global infusion pumps market is estimated ... to 2021, to reach USD 10.84 billion by 2021 ... chronic diseases along with increasing geriatric population, increasing adoption ... increase in surgical procedural volumes, and rising applications of ... key factors driving the growth of this market. However, ...
(Date:2/21/2017)... 21, 2017  Luminex Corporation (NASDAQ: LMNX ) ... authorized the initiation of a quarterly cash dividend to its ... dividend will be payable on April 14, 2017 to shareholders ... 24, 2017. The board of directors intends ... of $0.06 to holders of its common stock, representing a ...
(Date:2/21/2017)... , Feb. 21, 2017 Medical ... full report: http://www.reportlinker.com/p04711311-summary/view-report.html Medical oxygen ... and other respiratory diseases. Patients having low level ... use oxygen concentrators. Oxygen concentrators are to be ... over the counter. Medical oxygen concentrators work either ...
Breaking Medicine Technology: